Last reviewed · How we verify
Tetanus toxoid adsorbed booster vaccine
Tetanus toxoid adsorbed booster vaccine is a Biologic drug developed by Genentech, Inc.. It is currently in Phase 2 development.
At a glance
| Generic name | Tetanus toxoid adsorbed booster vaccine |
|---|---|
| Sponsor | Genentech, Inc. |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Immunosuppression and COVID-19 Boosters (PHASE3)
- Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents (PHASE3)
- Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine (PHASE1)
- Study of a Novel Multicomponent Meningococcal Group B Vaccine When Given Alone or With Other Licensed Vaccines in Adults, Adolescents, Toddlers and Infants (PHASE1)
- Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand (PHASE3)
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (PHASE3)
- Study to Evaluate the Immune Response After Booster Vaccination With Tdap-IPV Vaccine (Against Tetanus, Diphtheria, Pertussis and Poliomyelitis) in Children Who Received Different Pertussis Primary Vaccine Regimens in Republic of South Africa (PHASE4)
- Infant Malaria Vaccine Schedule Optimization (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tetanus toxoid adsorbed booster vaccine CI brief — competitive landscape report
- Tetanus toxoid adsorbed booster vaccine updates RSS · CI watch RSS
- Genentech, Inc. portfolio CI
Frequently asked questions about Tetanus toxoid adsorbed booster vaccine
What is Tetanus toxoid adsorbed booster vaccine?
Tetanus toxoid adsorbed booster vaccine is a Biologic drug developed by Genentech, Inc..
Who makes Tetanus toxoid adsorbed booster vaccine?
Tetanus toxoid adsorbed booster vaccine is developed by Genentech, Inc. (see full Genentech, Inc. pipeline at /company/genentech-inc).
What development phase is Tetanus toxoid adsorbed booster vaccine in?
Tetanus toxoid adsorbed booster vaccine is in Phase 2.